{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T17:14:59Z","timestamp":1787850899930,"version":"build-2784847793"},"update-to":[{"DOI":"10.1002\/14651858.cd000551.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2012,12,12]],"date-time":"2012-12-12T00:00:00Z","timestamp":1355270400000}}],"reference-count":230,"publisher":"Wiley","issue":"12","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd000551.pub3","type":"journal-article","created":{"date-parts":[[2012,12,6]],"date-time":"2012-12-06T18:48:17Z","timestamp":1354819697000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Ursodeoxycholic acid for primary biliary cirrhosis"],"prefix":"10.1002","volume":"2012","author":[{"given":"Jelena S","family":"Rudic","sequence":"first","affiliation":[{"name":"Clinic of Gastroenterology, Clinical Centre of Serbia; Department of Hepatology; Koste Todorovica 2 Belgrade Serbia 11000"},{"name":"Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 7812, Rigshospitalet, Copenhagen University Hospital; The Cochrane Hepato-Biliary Group; Blegdamsvej 9 Copenhagen Denmark DK-2100"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goran","family":"Poropat","sequence":"additional","affiliation":[{"name":"Clinical Hospital Centre Rijeka; Department of Gastroenterology; Kresimirova 42 Rijeka Croatia 51000"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miodrag N","family":"Krstic","sequence":"additional","affiliation":[{"name":"Clinic of Gastroenterology, Clinical Centre of Serbia, Medical Faculty, University of Belgrade; Belgrade Serbia 11000"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goran","family":"Bjelakovic","sequence":"additional","affiliation":[{"name":"Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 7812, Rigshospitalet, Copenhagen University Hospital; The Cochrane Hepato-Biliary Group; Blegdamsvej 9 Copenhagen Denmark DK-2100"},{"name":"Medical Faculty, University of Nis; Department of Internal Medicine; Zorana Djindjica 81 Nis Serbia 18000"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Gluud","sequence":"additional","affiliation":[{"name":"Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 7812, Rigshospitalet, Copenhagen University Hospital; The Cochrane Hepato-Biliary Group; Blegdamsvej 9 Copenhagen Denmark DK-2100"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,12,12]]},"reference":[{"key":"10.1002\/14651858.CD000551.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0168-8278(05)80214-4","article-title":"Ursodeoxycholic acid for symptomatic primary biliary cirrhosis. Preliminary analysis of a double-blind multicenter trial. Italian Multicenter Group for the Study of UDCA in PBC","volume":"17","author":"Battezzati","year":"1993","journal-title":"Journal of Hepatology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD000551.pub3-BIB0002|cit2","first-page":"87","article-title":"Ursodeoxycholic acid (UDCA) for symptomatic primary biliary cirrhosis (PBC): a double-blind multicenter trial (EASL abstract)","volume":"9","author":"Italian Multicenter Project for UDCA Treatment in PBC","year":"1989","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0003|cit3","unstructured":"Podda M Almasio P Battezzati PM Crosignani A and Italian Multicenter Group for the Study of UDCA in PBC Long-term effect of the administration of ursodeoxycholic acid alone or with colchicine in patients with primary biliary cirrhosis: a double-blind multicenter study Bile Acids and the Hepatobiliary System. From Basic Science to Clinical Practice. Falk Symposium 68 1993 310 5"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0004|cit4","first-page":"639","article-title":"Urodeoxycholic acid (UDCA) for symptomatic primary biliary cirrhosis (PBC): a double-blind multicenter trial [AASLD abstract]","volume":"10","author":"Podda","year":"1989","journal-title":"Hepatology"},{"issue":"4","key":"10.1002\/14651858.CD000551.pub3-BIB0005|cit5","first-page":"A1163","article-title":"Extended follow-up of patients in the U.S. multicenter trial of ursodeoxycholic acid for primary biliary cirrhosis (Abstract)","volume":"110","author":"Carithers","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0006|cit6","first-page":"759","article-title":"A randomised, double-blind, placebo-controlled trial of ursodeoxycholic acid in primary biliary cirrhosis","volume":"22","author":"Combes","year":"1995","journal-title":"Hepatology"},{"issue":"6","key":"10.1002\/14651858.CD000551.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1002\/hep.510290618","article-title":"Biliary bile acids in primary biliary cirrhosis: effect of ursodeoxycholic acid","volume":"29","author":"Combes","year":"1999","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0008|cit8","first-page":"91A","article-title":"Ursodeoxycholic acid therapy in patients with primary biliary cirrhosis [AASLD abstract]","volume":"14","author":"Combes","year":"1991","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"175A","DOI":"10.1016\/0270-9139(93)92227-Q","article-title":"A randomised, double-blind, placebo-controlled trial of ursodeoxycholic acid (UDCA) in primary biliary cirrhosis (AASLD Abstract)","volume":"18","author":"Combes","year":"1993","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0010|cit10","unstructured":"Combes B Carithers RL Maddrey WC Munoz SJ McDonald MF Garcia-Tsao G A randomised, double-blind, placebo-controlled trial of ursodeoxycholic acid (UDCA) in primary biliary cirrhosis (PBC) Falk Symposium No. 68. XII International Bile Acid Meeting. Bile Acids and the Hepatobiliary System. From Basic Science to Clinical Practice. Basel 1992 43"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0011|cit11","unstructured":"Combes B Carithers RL Maddrey WC Munoz SJ McDonald MF Garcia-Tsao G A randomised, double-blind, placebo-controlled trial of ursodeoxycholic acid in primary biliary cirrhosis Bile Acids and the Hepatobiliary System. From Basic Science to Clinical Practice. Falk Symposium 68 1993 289 91"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0012|cit12","unstructured":"Combes B Carithers RL Maddrey WC Munoz SJ McDonald MF Garcia-Tsao G The American multicenter primary biliary cirrhosis, Ursodiol versus placebo study group (PUPS) trial Falk Symposium No. 80. XIII International Bile Acid Meeting. Bile Acids in Gastroenterology: Basic and Clinical Aspects. San Diego 1994 67"},{"issue":"9","key":"10.1002\/14651858.CD000551.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1572-0241.2004.04047.x","article-title":"Prolonged follow-up of patients in the U.S. multicenter trial of ursodeoxycholic acid for primary biliary cirrhosis","volume":"99","author":"Combes","year":"2004","journal-title":"The American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1002\/hep.510300315","article-title":"The effect of ursodeoxycholic acid on the florid duct lesion of primary biliary cirrhosis","volume":"30","author":"Combes","year":"1999","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0015|cit15","first-page":"168A","article-title":"Does ursodeoxycholic acid improve survival in patients with primary biliary cirrhosis? Comparison of outcome in the US multicenter trial to expected survival using the Mayo Clinic prognostic model [AASLD abstract]","volume":"24","author":"Emond","year":"1996","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"57I","DOI":"10.1016\/0270-9139(94)90396-4","article-title":"Does treatment with ursodeoxycholic acid (UDCA) really diminish cholesterol serum levels in primary biliary cirrhosis (PBC)? [EASL abstract]","volume":"19","author":"Mora","year":"1994","journal-title":"Hepatology"},{"issue":"Suppl 209","key":"10.1002\/14651858.CD000551.pub3-BIB0017|cit17","first-page":"35","article-title":"Ursodeoxycholic acid (UDCA) in patients with primary biliary cirrhosis (PBC) Results of a two-year randomised placebo-controlled study (abstract)","volume":"30","author":"Eriksson","year":"1995","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3109\/00365529709000190","article-title":"Ursodeoxycholic acid treatment in patients with primary biliary cirrhosis. A Swedish multicenter, double-blind, randomised controlled study","volume":"32","author":"Eriksson","year":"1997","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0019|cit19","first-page":"151A","article-title":"A trial of ursodeoxycholic acid (UDCA) and colchicine in primary biliary cirrhosis (PBC) (AASLD abstract)","volume":"20","author":"Goddard","year":"1994","journal-title":"Hepatology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD000551.pub3-BIB0020|cit20","first-page":"A30","article-title":"Surrogate markers of response in a trial of ursodeoxycholic acid (UDCA) and colchicine in primary biliary cirrhosis (PBC)","volume":"36","author":"Goddard","year":"1995","journal-title":"Gut"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0021|cit21","first-page":"438 A","article-title":"Ursodeoxycholic acid therapy effects on pruritus and fatigue in primary biliary cirrhosis","volume":"26","author":"Ghent","year":"1997","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1002\/hep.1840190512","article-title":"The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis","volume":"19","author":"Heathcote","year":"1994","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0023|cit23","unstructured":"Heathcote EJL Cauch K Walker V Bailey RJ Blendis LM Ghent CN A double blind randomised controlled multi-centre trial of ursodeoxycholic acid (UDCA) in primary biliary cirrhosis (PBC): results from a blinded interim analysis XII International Bile Acid Meeting. Bile Acids and the Hepatobiliary System. From Basic Science to Clinical Practice. Basel. Falk Symposium No. 68 1992 45"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0024|cit24","first-page":"91A","article-title":"The Canadian multi-centre double blind randomised controlled trial of ursodeoxycholic acid in primary biliary cirrhosis [AASLD abstract]","volume":"16","author":"Heathcote","year":"1992","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0025|cit25","first-page":"A914","article-title":"A four-year follow-up study of ursodeoxycholic acid therapy for primary biliary cirrhosis","volume":"104","author":"Heathcote","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0026|cit26","unstructured":"Heathcote EJL Cauch K Walker V Blendis LM Pappas SC Wanless IR A double-blind randomised controlled multicenter trial of ursodeoxycholic acid in primary biliary cirrhosis: results from a 1991 interim analysis Bile Acids and the Hepatobiliary System. From Basic Science to Clinical Practice. Falk Symposium 68 1993 294 8"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD000551.pub3-BIB0027|cit27","first-page":"96","article-title":"Is the Mayo model useful for predicting survival following the introduction of ursodeoxycholic acid treatment for primary biliary cirrhosis? [abstract]","volume":"108","author":"Kilmurry","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0028|cit28","first-page":"1148","article-title":"Is the Mayo model for predicting survival useful after the introduction of ursodeoxycholic acid treatment for primary biliary cirrhosis?","volume":"23","author":"Kilmurry","year":"1996","journal-title":"Hepatology"},{"issue":"4","key":"10.1002\/14651858.CD000551.pub3-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"217A","DOI":"10.1016\/0270-9139(93)92390-L","article-title":"No evidence for a more atherogenic serum lipid profile with ursodeoxycholic acid (UDCA) therapy in patients with primary biliary cirrhosis (PBC) [abstract]","volume":"18","author":"Michieletti","year":"1993","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0030|cit30","unstructured":"Neuman MG Cameron RG Shear NH Blendis LM Ursodeoxycholic acid reduces fibrosis in primary biliary cirrhosis (Abstract) XV International Bile Acid Meeting. Bile Acids and Cholestasis. Titisee, Germany. Falk Symposium No 108 1998 59"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1440-1746.1993.tb01189.x","article-title":"Ursodeoxycholic acid in the treatment of primary biliary cirrhosis: a short-term, randomised, double-blind controlled, cross-over study with long-term follow up","volume":"8","author":"Hwang","year":"1993","journal-title":"Journal of Gastroenterology and Hepatology"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0032|cit32","first-page":"49","article-title":"Treatment of chronic active hepatitis and primary biliary cirrhosis with ursodeoxycholic acid","volume":"30 Suppl 1","author":"G\u00fcld\u00fctuna","year":"1992","journal-title":"Zeitschrift fur Gastroenterologie"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0033|cit33","unstructured":"Leuschner M G\u00fcld\u00fctuna S Imhof M Bhati S You T Leuschner U Ursodeoxycholic acid therapy in primary biliary cirrhosis Bile acids and the hepatobiliary system. From Basic Science to Clinical Practice. Falk Symposium 68 1993 299 302"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0034|cit34","first-page":"A621","article-title":"Does ursodeoxycholic acid (UDCA) influence cell membrane architecture in patients with primary biliary cirrhosis (PBC)?","volume":"96","author":"Leuschner","year":"1989","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0035|cit35","first-page":"133","article-title":"[Ursodeoxycholic acid in the treatment of primary biliary cirrhosis: results of a controlled study]","volume":"24","author":"Leuschner","year":"1989","journal-title":"Zeitschrift fur Gastroenterologie. Verhandlungsband"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/0016-5085(89)91698-3","article-title":"Ursodeoxycholic acid in primary biliary cirrhosis: results of a controlled double-blind trial","volume":"97","author":"Leuschner","year":"1989","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0037|cit37","unstructured":"Leuschner U Fisher H H\u00fcbner K G\u00fcld\u00fctuna S Gatzen M Hellstern A Ursodeoxycholic acid (UDCA) treatment of primary biliary cirrhosis: clinical and histological results of a controlled study Trends in Bile Acid Research. Falk Symposium 52 1989 355 8"},{"issue":"2","key":"10.1002\/14651858.CD000551.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1478-3231.1999.tb00020.x","article-title":"Utilization of the Mayo risk score in patients with primary biliary cirrhosis receiving ursodeoxycholic acid","volume":"19","author":"Angulo","year":"1999","journal-title":"Liver"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S0025-6196(12)61815-1","article-title":"Effect of ursodeoxycholic acid on serum lipids of patients with primary biliary cirrhosis [see comments]","volume":"69","author":"Balan","year":"1994","journal-title":"Mayo Clinic Proceedings"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"175A","DOI":"10.1016\/0270-9139(93)92228-R","article-title":"The effects of ursodeoxycholic acid on hepatic inflammation and histological stage in patients with primary biliary cirrhosis (AASLD Abstract)","volume":"18","author":"Batts","year":"1993","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0041|cit41","first-page":"2314","article-title":"Effects of ursodeoxycholic acid on hepatic inflammation and histological stage in patients with primary biliary cirrhosis","volume":"91","author":"Batts","year":"1996","journal-title":"American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0044|cit42","unstructured":"Dickson ER Lindor KD Beneficial effects of ursodeoxycholic acid in an open trial of patients with primary biliary cirrhosis Bile Acids as Therapeutic Agents. From Basic Science to Clinical Practice. Falk Symposium 58 1991 271 2"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0042|cit43","unstructured":"Dickson ER Lindor KD Baldus WP Jorgensen RA Ludwig J Murtaugh PA Ursodiol (URSO) is effective therapy for patients with primary biliary cirrhosis (PBC) Falk Symposium No. 68. XII International Bile Acid Meeting. Bile Acids and the Hepatobiliary System. From Basic Science to Clinical Practice. Basel 1992 44"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0043|cit44","unstructured":"Dickson ER Lindor KD Baldus WP Jorgensen RA Ludwig J Murtaugh PA Ursodiol is effective therapy for patients with primary biliary cirrhosis Bile Acids and the Hepatobiliary System. From Basic Science to Clinical Practice. Falk Symposium 68 1993 292 3"},{"issue":"10","key":"10.1002\/14651858.CD000551.pub3-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1111\/j.1572-0241.2002.06043.x","article-title":"Results of long-term ursodiol treatment for patients with primary biliary cirrhosis","volume":"97","author":"Jorgensen","year":"2002","journal-title":"American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1136\/gut.36.6.935","article-title":"Characterisation of patients with a complete biochemical response to ursodeoxycholic acid","volume":"36","author":"Jorgensen","year":"1995","journal-title":"Gut"},{"issue":"4","key":"10.1002\/14651858.CD000551.pub3-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"174 A","DOI":"10.1016\/0270-9139(93)92221-K","article-title":"Dissimilar patterns of serum and biliary bile acids in primary biliary cirrhosis (PBC) patients treated with ursodeoxycholic acid (UDCA)","volume":"18","author":"Lacerda","year":"1993","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0048|cit48","first-page":"1840","article-title":"The natural history of abdominal pain associated with primary biliary cirrhosis","volume":"89","author":"Laurin","year":"1994","journal-title":"American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0049|cit49","first-page":"91A","article-title":"Ursodeoxycholic acid (UDCA) is beneficial therapy for patients with primary biliary cirrhosis (PBC) [AASLD abstract]","volume":"16","author":"Lindor","year":"1992","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/0016-5085(94)90021-3","article-title":"Ursodeoxycholic acid in the treatment of primary biliary cirrhosis [see comments]","volume":"106","author":"Lindor","year":"1994","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1002\/14651858.CD000551.pub3-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"125A","DOI":"10.1016\/0270-9139(95)94225-4","article-title":"Ursodeoxycholic acid delays the onset of oesophageal varices in primary biliary cirrhosis [abstract]","volume":"22","author":"Lindor","year":"1995","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.4065\/72.12.1137","article-title":"Ursodeoxycholic acid delays the onset of oesophageal varices in primary biliary cirrhosis","volume":"72","author":"Lindor","year":"1997","journal-title":"Mayo Clinic Proceedings"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1111\/j.1572-0241.1998.00470.x","article-title":"Relationship between biliary and serum bile acids and response to ursodeoxycholic acid in patients with primary biliary cirrhosis","volume":"93","author":"Lindor","year":"1998","journal-title":"American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1053\/gast.1996.v110.pm8613058","article-title":"Effects of ursodeoxycholic acid on survival in patients with primary biliary cirrhosis","volume":"110","author":"Lindor","year":"1996","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1002\/14651858.CD000551.pub3-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"A1111","DOI":"10.1016\/0016-5085(95)28744-2","article-title":"Effects of ursodeoxycholic acid (UDCA) on survival in patients with primary biliary cirrhosis (PBC) [AASLD abstract]","volume":"108","author":"Lindor","year":"1995","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1002\/14651858.CD000551.pub3-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/00004836-200308000-00018","article-title":"Treatment with ursodeoxycholic acid is associated with weight gain in patients with primary biliary cirrhosis","volume":"37","author":"Siegel","year":"2003","journal-title":"Journal of Clinical Gastroenterology"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1111\/j.1572-0241.1998.00287.x","article-title":"Autoimmune conditions associated with primary biliary cirrhosis: response to ursodeoxycholic acid therapy","volume":"93","author":"Zukowski","year":"1998","journal-title":"American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1007\/BF02779195","article-title":"A multicenter double-blind controlled trial of ursodeoxycholic acid for primary biliary cirrhosis","volume":"25","author":"Oka","year":"1990","journal-title":"Gastroenterologia Japonica"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0059|cit59","unstructured":"Toda G Oka H Hasumura Y Kamimura T Ohat Y Tsuji T A multicenter double-blind controlled trial of ursodeoxycholic acid for primary biliary cirrhosis in Japan XI International Bile Acid Meeting. Bile Acids as Therapeutic Agents - From Basic Science to Clinical Practice. Freiburg 1990 76"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0060|cit60","first-page":"1421","article-title":"A randomised controlled trial of ursodeoxycholic acid (UDCA) in primary biliary cirrhosis (PBC) (AASLD Abstract)","volume":"8","author":"Hadziyannis","year":"1988","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0063|cit61","unstructured":"Hadziyannis SJ Long-term treatment of primary biliary cirrhosis with ursodeoxycholic acid: the third year of a controlled trial XI International Bile Acid Meeting. Bile Acids as Therapeutic Agents - From Basic Science to Clinical Practice. Freiburg 1990 57 8"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0061|cit62","unstructured":"Hadziyannis SJ Hadziyannis ES Lianidou E Makris A Long-term treatment of primary biliary cirrhosis with ursodeoxycholic acid: the third year of a controlled trial Bile Acids as Therapeutic Agents. From Basic Science to Clinical Practice. Falk Symposium 58 1990 287 96"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0062|cit63","first-page":"580","article-title":"A randomised controlled trial of ursodeoxycholic acid (UDCA) in primary biliary cirrhosis (PBC) [abstract]","volume":"10","author":"Hadziyannis","year":"1989","journal-title":"Hepatology"},{"issue":"Pt 2","key":"10.1002\/14651858.CD000551.pub3-BIB0064|cit64","first-page":"A15","article-title":"A randomised controlled trial of Ursodeoxyccholic acid (UDCA) in primary biliary cirrhosis (PBC)","volume":"19","author":"Hadziyannis","year":"1989","journal-title":"European Journal of Clinical Investigation"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD000551.pub3-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0168-8278(00)80485-7","article-title":"Ursodeoxycholic-acid for primary biliary cirrhosis: final results of a 12-year prospective, randomised, controlled trial","volume":"32","author":"Papatheodoridis","year":"2000","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1111\/j.1572-0241.2002.05923.x","article-title":"Ursodeoxycholic acid for primary biliary cirrhosis: final results of a 12-year, prospective, randomised, controlled trial","volume":"97","author":"Papatheodoridis","year":"2002","journal-title":"American Journal of Gastroenterology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD000551.pub3-BIB0069|cit67","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0168-8278(01)81572-5","article-title":"Factors influencing histological progression of early primary biliary cirrhosis. Effect of ursodeoxycholic acid","volume":"34","author":"Pares","year":"2001","journal-title":"Journal of Hepatology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD000551.pub3-BIB0070|cit68","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0168-8278(01)80689-9","article-title":"Long-term ursodeoxycholic acid treatment delays progression of mild primary biliary cirrhosis","volume":"34","author":"Pares","year":"2001","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0067|cit69","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0168-8278(00)80216-0","article-title":"Long-term effects of ursodeoxycholic acid in primary biliary cirrhosis: results of a double-blind controlled multicentric trial","volume":"32","author":"Par\u00e9s","year":"2000","journal-title":"Journal of Hepatology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD000551.pub3-BIB0068|cit70","first-page":"166","article-title":"Long-term treatment of primary biliary cirrhosis with ursodeoxycholic acid: results of a randomised, double-blind, placebo-controlled trial (abstract)","volume":"26","author":"Par\u00e9s","year":"1997","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/0300-9084(91)90098-L","article-title":"Ursodeoxycholic acid (UDCA) in the treatment of chronic cholestatic diseases","volume":"73","author":"Calmus","year":"1991","journal-title":"Biochimie"},{"issue":"4","key":"10.1002\/14651858.CD000551.pub3-BIB0072|cit72","first-page":"125A","article-title":"Histological course of primary biliary cirrhosis (PBC) treated with ursodeoxycholic acid (UDCA) [abstract]","volume":"2","author":"Chazouilleres","year":"1995","journal-title":"Hepatology"},{"issue":"4","key":"10.1002\/14651858.CD000551.pub3-BIB0073|cit73","first-page":"474A","article-title":"A Markov model for assessment of histological progression in PBC provides evidence that UDCA therapy is effective in early stages [abstract]","volume":"30","author":"Corpechot","year":"1999","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1053\/jhep.2000.20240","article-title":"The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhosis","volume":"32","author":"Corpechot","year":"2000","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/hep.510290444","article-title":"Histopathologic study of primary biliary cirrhosis and the effect of ursodeoxycholic acid treatment on histological progression","volume":"29","author":"Degott","year":"1999","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0076|cit76","first-page":"202A","article-title":"Long term effect of ursodeoxycholic acid (UDCA) on hepatic function and portal hypertension in primary biliary cirrhosis (PBC) [AASLD abstract]","volume":"20","author":"Huet","year":"1994","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0078|cit77","unstructured":"Huet PM Willems B Huet J Poupon R Effects of ursodeoxycholic acid (UDCA) on hepatic function and portal hypertension in primary biliary cirrhosis (PBC) XII International Bile Acid Meeting. Bile Acids and the Hepatobiliary System. From Basic Science to Clinical Practice. Basel. Falk Symposium No. 68 1992 118"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0077|cit78","first-page":"907","article-title":"Effects of ursodeoxycholic acid (UDCA) on hepatic function and portal hypertension in primary biliary cirrhosis (PBC) [AASLD abstract]","volume":"12","author":"Huet","year":"1990","journal-title":"Hepatology"},{"issue":"3","key":"10.1002\/14651858.CD000551.pub3-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/S0168-8278(99)80098-1","article-title":"Clinical and biochemical expression of the histopathological lesions of primary biliary cirrhosis UDCA-PBC Group","volume":"30","author":"Poupon","year":"1999","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0080|cit80","unstructured":"Poupon R Poupon RE The UDCA-PBC Group Ursodeoxycholic acid in the treatment of primary biliary cirrhosis Strategies for the Treatment of Hepatobiliary Diseases. Falk Symposium 53 1990 79 81"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0081|cit81","unstructured":"Poupon R Poupon RE the UDCA-PBC Group Ursodeoxycholic acid for primary biliary cirrhosis International Lugano Symposium on Biliary Physiology and Diseases: Strategies for the Treatment of Hepatobiliary Diseases. Lugano. Falk Symposium No. 53 1989 22"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0082|cit82","unstructured":"Poupon R the UDCA-PBC Group Ursodeoxycholic acid in the treatment of primary biliary cirrhosis First International Symposium. Trends and Discovery in Bile Acid Research. Bora-Bora (French Polynesia) 1990 123 6"},{"issue":"6 Suppl 2","key":"10.1002\/14651858.CD000551.pub3-BIB0083|cit83","first-page":"48","article-title":"A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis","volume":"115","author":"Poupon","year":"1991","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1056\/NEJM199105303242204","article-title":"A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis","volume":"324","author":"Poupon","year":"1991","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/hep.1840190314","article-title":"Predictive factors in ursodeoxycholic acid-treated patients with primary biliary cirrhosis: role of serum markers of connective tissue","volume":"19","author":"Poupon","year":"1994","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0086|cit86","first-page":"872","article-title":"Beneficial effect of ursodeoxycholic acid (UDCA) in primary biliary cirrhosis (PBC). Final results of the French Canadian trial [AASLD abstract]","volume":"12","author":"Poupon","year":"1990","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0088|cit87","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/hep.1840170412","article-title":"Serum bile acids in primary biliary cirrhosis: effect of ursodeoxycholic acid therapy","volume":"17","author":"Poupon","year":"1993","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0087|cit88","first-page":"91A","article-title":"Ursodeoxycholic therapy for primary biliary cirrhosis: a four year controlled study","volume":"16","author":"Poupon","year":"1992","journal-title":"Hepatology"},{"issue":"1","key":"10.1002\/14651858.CD000551.pub3-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/0168-8278(90)90265-S","article-title":"Ursodeoxycholic acid for the treatment of primary biliary cirrhosis. Interim analysis of a double-blind multicenter randomised trial. The UDCA-PBC Study Group","volume":"11","author":"Poupon","year":"1990","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/hep.1840170408","article-title":"Cholesterol-lowering effect of ursodeoxycholic acid in patients with primary biliary cirrhosis","volume":"17","author":"Poupon","year":"1993","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1056\/NEJM199405123301903","article-title":"Ursodiol for the long-term treatment of primary biliary cirrhosis. The UDCA-PBC Study Group [see comments]","volume":"330","author":"Poupon","year":"1994","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0092|cit92","first-page":"639","article-title":"Ursodeoxycholic acid (UDCA) for treatment of primary biliary cirrhosis (PBC). Interim analysis of a double-blind multicenter randomised trial","volume":"10","author":"Poupon","year":"1989","journal-title":"Hepatology"},{"issue":"4","key":"10.1002\/14651858.CD000551.pub3-BIB0093|cit93","first-page":"994","article-title":"Effect of ursodiol on bile acid conjugation in patients with primary biliary cirrhosis [AASLD abstract]","volume":"12","author":"Arora","year":"1990","journal-title":"Hepatology"},{"issue":"2","key":"10.1002\/14651858.CD000551.pub3-BIB0094|cit94","first-page":"A567","article-title":"Effect of ursodiol on biliary bile acid composition and conjugation in patients with primary biliary cirrhosis","volume":"98","author":"Batta","year":"1990","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0095|cit95","first-page":"A617","article-title":"Ursodiol treatment of primary biliary cirrhosis","volume":"98","author":"O'Brian","year":"1990","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0096|cit96","unstructured":"O'Brian CB Senior JR Sternlieb JM Saul SM Caution: not all patients with primary biliary cirrhosis may successfully be treated by ursodiol Second International Meeting on Pathochemistry, Pathophysiology and Pathomechanisms of the Biliary System and New Strategies for the Treatment of Hepato-Biliary Diseases. Bologna 1990 208"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0097|cit97","first-page":"438","article-title":"Effect of oral ursodiol treatment on the predicted probability of mortality in primary biliary cirrhosis","volume":"12","author":"Senior","year":"1990","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0098|cit98","unstructured":"Senior JR O'Brien CB Mortality risk indices as outcome measures of the effectiveness of ursodeoxycholic acid treatment of cholestatic liver diseases Bile Acids as Therapeutic Agents. From Basic Science to Clinical Practice. Falk Symposium 58 1991 273 85"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0099|cit99","first-page":"415","article-title":"No symptomatic or histological benefit from ursodeoxycholic acid treatment in PBC after 1 year. Controlled pilot study [IASL abstract]","volume":"12","author":"Myszor","year":"1990","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1440-1746.1994.tb01237.x","article-title":"A two year controlled trial examining the effectiveness of ursodeoxycholic acid in primary biliary cirrhosis","volume":"9","author":"Turner","year":"1994","journal-title":"Journal of Gastroenterology and Hepatology"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/BF00196579","article-title":"Ursodeoxycholic acid treatment lowers the serum levels of antibodies against pyruvate dehydrogenase and influences their inhibitory capacity for the enzyme complex in patients with primary biliary cirrhosis","volume":"74","author":"Kisand","year":"1996","journal-title":"Journal of Molecular Medicine"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0103|cit102","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/0270-9139(95)90046-2","article-title":"Serum cholestanol, cholesterol precursors, and plant sterols during placebo-controlled treatment of primary biliary cirrhosis with ursodeoxycholic acid or colchicine","volume":"21","author":"Miettinen","year":"1995","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0102|cit103","first-page":"A954","article-title":"Improvement of serum non cholesterol sterols may indicate retarded progression of primary biliary cirrhosis (PBC) in a randomised placebo controlled two-year trial with colchicine and ursodeoxycholic acid (AASLD abstract)","volume":"104","author":"Miettinen","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0105|cit104","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/0016-5085(95)90696-7","article-title":"A placebo-controlled trial of primary biliary cirrhosis treatment with colchicine and ursodeoxycholic acid [see comments]","volume":"108","author":"Vuoristo","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0104|cit105","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0168-8278(97)80293-0","article-title":"Expression and therapeutic response related to apolipoprotein E polymorphism in primary biliary cirrhosis","volume":"27","author":"Vuoristo","year":"1997","journal-title":"Journal of Hepatology"},{"issue":"3","key":"10.1002\/14651858.CD000551.pub3-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/hep.510290301","article-title":"Long-term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis","volume":"29","author":"Angulo","year":"1999","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/S0168-8278(99)80136-6","article-title":"Comparison of three doses of ursodeoxycholic acid in the treatment of primary biliary cirrhosis: a randomised trial","volume":"30","author":"Angulo","year":"1999","journal-title":"Journal of Hepatology"},{"issue":"874","key":"10.1002\/14651858.CD000551.pub3-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1136\/pgmj.74.874.482","article-title":"Ursodeoxycholic acid therapy for primary biliary cirrhosis. A 10-year British single-centre population-based audit of efficacy and survival","volume":"74","author":"Bateson","year":"1998","journal-title":"Postgraduate Medical Journal"},{"issue":"7","key":"10.1002\/14651858.CD000551.pub3-BIB0109|cit109","first-page":"215","article-title":"Ursodeoxycholic acid in the treatment of primary biliary cirrhosis","volume":"136","author":"Brodanova","year":"1997","journal-title":"Casopis Lekaru Ceskych"},{"issue":"5","key":"10.1002\/14651858.CD000551.pub3-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1136\/gut.43.5.705","article-title":"Fatigue in primary biliary cirrhosis","volume":"43","author":"Cauch-Dudek","year":"1998","journal-title":"Gut"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0111|cit111","first-page":"367","article-title":"Prolonged treatment with ursodeoxycholic acid for primary biliary cirrhosis","volume":"146","author":"Crippa","year":"1995","journal-title":"Clinical Therapeutics"},{"issue":"4","key":"10.1002\/14651858.CD000551.pub3-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/BF02213140","article-title":"Tauroursodeoxycholic acid for treatment of primary biliary cirrhosis. A dose-response study","volume":"41","author":"Crosignani","year":"1996","journal-title":"Digestive Diseases and Sciences"},{"issue":"34","key":"10.1002\/14651858.CD000551.pub3-BIB0113|cit113","first-page":"695","article-title":"Treatment of primary biliary cirrhosis with ursodeoxycholic acid. Part 2: Prospective long-term trial in 21 patients","volume":"106","author":"Eisenburg","year":"1988","journal-title":"Fortschritte der Medizin"},{"issue":"4","key":"10.1002\/14651858.CD000551.pub3-BIB0114|cit114","first-page":"321","article-title":"Tauroursodeoxycholic acid for treatment of primary biliary cirrhosis. A controlled comparison with ursodeoxycholic acid","volume":"143","author":"Ferri","year":"1993","journal-title":"Clinica Terapeutica"},{"issue":"5","key":"10.1002\/14651858.CD000551.pub3-BIB0115|cit115","first-page":"367","article-title":"Prolonged treatment with ursodeoxycholic acid for primary biliary cirrhosis","volume":"146","author":"Crippa","year":"1995","journal-title":"Clinica Terapeutica"},{"issue":"1","key":"10.1002\/14651858.CD000551.pub3-BIB0116|cit116","first-page":"62","article-title":"Efficacy of ursodeoxycholic acid in lowering alanine aminotransferase and gamma-glutamyl transpeptidase serum levels in patients with chronic active hepatitis and primary biliary cirrhosis","volume":"47","author":"Id\u00e9o","year":"1990","journal-title":"Current Therapeutic Research Clinical and Experimental"},{"issue":"1","key":"10.1002\/14651858.CD000551.pub3-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0168-8278(96)80191-7","article-title":"Effects of additional administration of colchicine in ursodeoxycholic acid-treated patients with primary biliary cirrhosis: A prospective randomised study","volume":"24","author":"Ikeda","year":"1996","journal-title":"Journal of Hepatology"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD000551.pub3-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"S134","DOI":"10.1016\/0168-8278(91)91511-E","article-title":"Effect of UDCA on the natural course of PBC","volume":"13","author":"Kehagioglou","year":"1991","journal-title":"Journal of Hepatology"},{"issue":"1","key":"10.1002\/14651858.CD000551.pub3-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/hep.510260103","article-title":"Does antimitochondrial antibody status affect response to treatment in patients with primary biliary cirrhosis? Outcomes of ursodeoxycholic acid therapy and liver transplantation","volume":"26","author":"Kim","year":"1997","journal-title":"Hepatology"},{"issue":"1","key":"10.1002\/14651858.CD000551.pub3-BIB0120|cit120","first-page":"11","article-title":"Ursodeoxycholic acid treatment in primary biliary cirrhosis with the emphasis on late stage disease","volume":"41","author":"Kneppelhout","year":"1992","journal-title":"Netherlands Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD000551.pub3-BIB0121|cit121","first-page":"231","article-title":"Effects of ursodeoxycholic acid treatment on bilirubin concentration and survival of patients with primary biliary cirrhosis","volume":"6","author":"Krzeski","year":"1999","journal-title":"Gastroenterologia Polska"},{"issue":"2","key":"10.1002\/14651858.CD000551.pub3-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1046\/j.1365-2036.1997.124295000.x","article-title":"Ursodeoxycholic and tauro-ursodeoxycholic acids for the treatment of primary biliary cirrhosis: A pilot crossover study","volume":"11","author":"Larghi","year":"1997","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"1","key":"10.1002\/14651858.CD000551.pub3-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0168-8278(96)80327-8","article-title":"Ursodeoxycholic acid and prednisolone versus ursodeoxycholic acid and placebo in the treatment of early stages of primary biliary cirrhosis","volume":"25","author":"Leuschner","year":"1996","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0124|cit124","doi-asserted-by":"crossref","unstructured":"Verma A Ahmed HA Jazrawi RP Davis T Bland M Benson M Determining the most efficacious dose of ursodeoxycholic acid in primary biliary cirrhosis (Abstract) XV International Bile Acid Meeting. Bile Acids and Cholestasis. Falk Symposium No 108. Titisee, Germany 1998 62","DOI":"10.1016\/S0016-5085(98)85520-0"},{"issue":"3","key":"10.1002\/14651858.CD000551.pub3-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/0168-8278(90)90134-D","article-title":"Ursodeoxycholic acid in primary biliary cirrhosis: No evidence for toxicity in the stages I to III","volume":"10","author":"Lotterer","year":"1990","journal-title":"Journal of Hepatology"},{"issue":"1","key":"10.1002\/14651858.CD000551.pub3-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/00004836-199401000-00010","article-title":"Biochemical and histological changes after more than four years of treatment of ursodeoxycholic acid in primary biliary cirrhosis","volume":"18","author":"Matsuzaki","year":"1994","journal-title":"Journal of Clinical Gastroenterology"},{"issue":"1","key":"10.1002\/14651858.CD000551.pub3-BIB0127|cit127","first-page":"15","article-title":"Improvement of biliary enzyme levels and itching as a result of long-term administration of ursodeoxycholic acid in primary biliary cirrhosis","volume":"85","author":"Matsuzaki","year":"1990","journal-title":"American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0128|cit128","first-page":"438 A","article-title":"Comparison of three different doses of ursodeoxycholic acid in the treatment of primary biliary cirrhosis: a randomised trial","volume":"26","author":"Lindor","year":"1997","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0129|cit129","first-page":"1221A","article-title":"Ursodeoxycholic acid improves liver function and reduces serum and urinary endogenous bile acids in primary biliary cirrhosis","volume":"8","author":"Batta","year":"1988","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0130|cit130","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/S0022-2275(20)38207-9","article-title":"Characterization of serum and urinary bile acids in patients with primary biliary cirrhosis by gas-liquid chromatography-mass spectrometry: effect of ursodeoxycholic acid treatment","volume":"30","author":"Batta","year":"1989","journal-title":"Journal of Lipid Research"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/hep.1840100404","article-title":"Effect of ursodeoxycholic acid on bile acid metabolism in primary biliary cirrhosis","volume":"10","author":"Batta","year":"1989","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0132|cit132","first-page":"1065A","article-title":"Ursodeoxycholic acid treatment of primary biliary cirrhosis","volume":"83","author":"Eskreis","year":"1988","journal-title":"American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0133|cit133","first-page":"691","article-title":"Effect of long-term treatment with ursodiol on clinical and biochemical features and biliary bile acid metabolism in patients with primary biliary cirrhosis","volume":"88","author":"Batta","year":"1993","journal-title":"American Journal of Gastroenterology"},{"issue":"4","key":"10.1002\/14651858.CD000551.pub3-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"306","DOI":"10.2957\/kanzo.34.306","article-title":"Effect of ursodeoxycholic acid therapy on lymphocyte function of patients with primary biliary cirrhosis","volume":"34","author":"Ogino","year":"1993","journal-title":"Acta Hepatologica Japonica"},{"issue":"6","key":"10.1002\/14651858.CD000551.pub3-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2957\/kanzo.29.799","article-title":"A case of primary biliary cirrhosis - 4 years' treatment with 300 mg\/day ursodeoxycholic acid","volume":"29","author":"Okuyama","year":"1988","journal-title":"Acta Hepatologica Japonica"},{"issue":"12 Suppl","key":"10.1002\/14651858.CD000551.pub3-BIB0136|cit136","doi-asserted-by":"crossref","first-page":"49S","DOI":"10.1007\/BF01536663","article-title":"Effect of ursodeoxycholic acid in chronic hepatitis and primary biliary cirrhosis","volume":"34","author":"Osuga","year":"1989","journal-title":"Digestive Diseases and Sciences"},{"issue":"4","key":"10.1002\/14651858.CD000551.pub3-BIB0137|cit137","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/0016-5085(92)90781-S","article-title":"Progression of primary biliary cirrhosis with ursodeoxycholic acid therapy","volume":"102","author":"Perdigoto","year":"1992","journal-title":"Gastroenterology"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD000551.pub3-BIB0138|cit138","first-page":"S25","article-title":"Ursodeoxycholic acid for chronic liver diseases","volume":"10","author":"Podda","year":"1988","journal-title":"Journal of Clinical Gastroenterology"},{"issue":"12 Suppl","key":"10.1002\/14651858.CD000551.pub3-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"59S","DOI":"10.1007\/BF01536665","article-title":"Effect of different doses of ursodeoxycholic acid in chronic liver disease","volume":"34","author":"Podda","year":"1989","journal-title":"Digestive Diseases and Sciences"},{"issue":"8537","key":"10.1002\/14651858.CD000551.pub3-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/S0140-6736(87)91610-2","article-title":"Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis?","volume":"1","author":"Poupon","year":"1987","journal-title":"Lancet"},{"issue":"4","key":"10.1002\/14651858.CD000551.pub3-BIB0141|cit141","first-page":"637","article-title":"Ursodeoxycholic acid improves histologic features and progression of primary biliary cirrhosis","volume":"10","author":"Poupon","year":"1989","journal-title":"Hepatology"},{"issue":"5","key":"10.1002\/14651858.CD000551.pub3-BIB0142|cit142","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1002\/hep.510240520","article-title":"A randomised trial comparing colchicine and ursodeoxycholic acid combination to ursodeoxycholic acid in primary biliary cirrhosis","volume":"24","author":"Poupon","year":"1996","journal-title":"Hepatology"},{"issue":"4","key":"10.1002\/14651858.CD000551.pub3-BIB0143|cit143","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1159\/000201472","article-title":"Serial quantitative liver function tests in patients with primary biliary cirrhosis: A prospective long-term study","volume":"58","author":"Schonfeld","year":"1997","journal-title":"Digestion"},{"issue":"3","key":"10.1002\/14651858.CD000551.pub3-BIB0144|cit144","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1440-1746.1992.tb00980.x","article-title":"Combination therapy with ursodeoxycholic acid and colchicine for primary biliary cirrhosis","volume":"7","author":"Shibata","year":"1992","journal-title":"Journal of Gastroenterology and Hepatology"},{"issue":"3 I","key":"10.1002\/14651858.CD000551.pub3-BIB0145|cit145","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/hep.1840120308","article-title":"Ursodeoxycholic acid-induced changes of plasma and urinary bile acids in patients with primary biliary cirrhosis","volume":"12","author":"Stiehl","year":"1990","journal-title":"Hepatology"},{"issue":"6","key":"10.1002\/14651858.CD000551.pub3-BIB0146|cit146","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/00042737-199406000-00015","article-title":"Does cholestyramine reduce the efficacy of ursodeoxycholic acid in primary biliary cirrhosis?","volume":"6","author":"Taha","year":"1994","journal-title":"European Journal of Gastroenterology and Hepatology"},{"issue":"4","key":"10.1002\/14651858.CD000551.pub3-BIB0147|cit147","first-page":"376","article-title":"A case of primary biliary cirrhosis with a histological improvement after long-term therapy with ursodeoxycholic acid","volume":"45","author":"Takezaki","year":"1991","journal-title":"IRYO Japanese Journal of National Medical Services"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0148|cit148","first-page":"443","article-title":"Dose-dependency of effect of ursodeoxycholic acid on primary biliary cirrhosis: a randomised, double-blind controlled study","volume":"37","author":"Toda","year":"1998","journal-title":"Kan-Tan-Sui (Japan)"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0149|cit149","unstructured":"Unoura M Ogino H Mizuno Y Urabe T Matsushita E Kaneko S Effects of ursodeoxycholic acid on lymphocyte functions in primary biliary cirrhosis XI International Bile Acid Meeting. Bile Acids as Therapeutic Agents - From Basic Science to Clinical Practice. Freiburg 1990 Abstract No. 77"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0150|cit150","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S0168-8278(96)80293-5","article-title":"Single or multiple dose ursodeoxycholic acid for cholestatic liver disease: biliary enrichment and biochemical response","volume":"25","author":"Meeberg","year":"1996","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0151|cit151","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1046\/j.1365-2036.1998.00395.x","article-title":"A randomised trial in primary biliary cirrhosis comparing ursodeoxycholic acid in daily doses of either 10 mg\/kg or 20 mg\/kg. Dutch Multicentre PBC Study Group","volume":"12","author":"Hoogstraten","year":"1998","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"10","key":"10.1002\/14651858.CD000551.pub3-BIB0152|cit152","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1097\/00042737-199910000-00001","article-title":"Optimum dose of ursodeoxycholic acid in primary biliary cirrhosis","volume":"11","author":"Verma","year":"1999","journal-title":"European Journal of Gastroenterology and Hepatology"},{"issue":"19","key":"10.1002\/14651858.CD000551.pub3-BIB0153|cit153","first-page":"810","article-title":"Eosinophilia in primary biliary cirrhosis: Regression under therapy with ursodeoxycholic acid","volume":"124","author":"Wirth","year":"1994","journal-title":"Schweizerische Medizinische Wochenschrift"},{"issue":"15","key":"10.1002\/14651858.CD000551.pub3-BIB0154|cit154","first-page":"750","article-title":"Subtype pattern of antimitochondrial antibodies in primary biliary cirrhosis and response to ursodeoxycholic acid","volume":"125","author":"Wirth","year":"1995","journal-title":"Schweizerische Medizinische Wochenschrift"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0155|cit155","first-page":"84","article-title":"Combined treatment with ursodeoxycholic acid and prednisone in primary biliary cirrhosis","volume":"44","author":"Wolfhagen","year":"1994","journal-title":"The Netherlands Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD000551.pub3-BIB0156|cit156","doi-asserted-by":"crossref","first-page":"348","DOI":"10.2957\/kanzo.33.348","article-title":"A patient with asymptomatic primary biliary cirrhosis associated with eosinophilic infiltration and peripheral eosinophilia improved by the administration of ursodeoxycholic acid","volume":"33","author":"Yamazaki","year":"1992","journal-title":"Acta Hepatologica Japonica"},{"issue":"3","key":"10.1002\/14651858.CD000551.pub3-BIB0157|cit157","first-page":"516","article-title":"Eosinophilia in primary biliary cirrhosis","volume":"91","author":"Yamazaki","year":"1996","journal-title":"American Journal of Gastroenterology"},{"issue":"2","key":"10.1002\/14651858.CD000551.pub3-BIB0158|cit158","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2957\/kanzo.37.102","article-title":"Rapid improvement of intractable pruritus in a case with primary biliary cirrhosis by a combined therapy of ursodeoxycholic acid (UDCA) and cholestyramine (CS) - Serum bile acid analysis","volume":"37","author":"Yokomori","year":"1996","journal-title":"Acta Hepatologica Japonica"},{"issue":"1","key":"10.1002\/14651858.CD000551.pub3-BIB0159|cit159","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/hep.23637","article-title":"American Association for the Study of Liver Diseases endpoints conference: design and endpoints for clinical trials in primary biliary cirrhosis","volume":"52","author":"Silveira","year":"2010","journal-title":"Hepatology"},{"issue":"5","key":"10.1002\/14651858.CD000551.pub3-BIB0160|cit160","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/00005792-199409000-00005","article-title":"Primary biliary cirrhosis (classical article)","volume":"73","author":"Ahrens","year":"1994","journal-title":"Medicine-Baltimore"},{"issue":"5","key":"10.1002\/14651858.CD000551.pub3-BIB0161|cit161","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/S0168-8278(99)80136-6","article-title":"Comparison of three doses of ursodeoxycholic acid in the treatment of primary biliary cirrhosis: a randomised trial","volume":"30","author":"Angulo","year":"1999","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0162|cit162","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1471-2288-3-16","article-title":"A perfect correlate dose not a surrogate make","volume":"3","author":"Baker","year":"2003","journal-title":"BMC Medical Research Methodology"},{"issue":"4","key":"10.1002\/14651858.CD000551.pub3-BIB0163|cit163","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias","volume":"50","author":"Begg","year":"1994","journal-title":"Biometrics"},{"issue":"8","key":"10.1002\/14651858.CD000551.pub3-BIB0164|cit164","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.jclinepi.2007.10.007","article-title":"Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses","volume":"61","author":"Brok","year":"2008","journal-title":"Journal of Clinical Epidemiology"},{"issue":"6","key":"10.1002\/14651858.CD000551.pub3-BIB0165|cit165","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1002\/hep.1840140609","article-title":"Changes in bile acid composition in patients with primary biliary cirrhosis induced by ursodeoxycholic acid administration","volume":"14","author":"Crosignani","year":"1991","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0166|cit166","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/sim.4780060325","article-title":"Methods of combining randomised clinical trials: strengths and limitations","volume":"6","author":"DeMets","year":"1987","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0167|cit167","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Controlled Clinical Trials"},{"issue":"1","key":"10.1002\/14651858.CD000551.pub3-BIB0168|cit168","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hep.1840100102","article-title":"Prognosis\u00a0in\u00a0primary biliary cirrhosis:\u00a0model\u00a0for\u00a0decision making","volume":"10","author":"Dickson","year":"1989","journal-title":"Hepatology"},{"issue":"2","key":"10.1002\/14651858.CD000551.pub3-BIB0169|cit169","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2009.04.009","article-title":"EASL Clinical Practice Guidelines: management of cholestatic liver diseases","volume":"51","author":"European Association for the Study of the Liver","year":"2009","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0170|cit170","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"British Medical Journal"},{"issue":"1","key":"10.1002\/14651858.CD000551.pub3-BIB0171|cit171","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta7010","article-title":"How important are comprehensive literature searches and the assessment of trial quality in systematic reviews? Empirical study.","volume":"7","author":"Egger","year":"2003","journal-title":"Health Technology Assessment"},{"issue":"5","key":"10.1002\/14651858.CD000551.pub3-BIB0172|cit172","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0168-8278(01)00061-7","article-title":"Ursodeoxycholic acid for primary biliary cirrhosis - lessons for the future","volume":"34","author":"Gluud","year":"2001","journal-title":"Journal of Hepatology"},{"issue":"6","key":"10.1002\/14651858.CD000551.pub3-BIB0173|cit173","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/aje\/kwj069","article-title":"Bias in clinical intervention research","volume":"163","author":"Gluud","year":"2006","journal-title":"American Journal of Epidemiology"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0174|cit174","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.jhep.2007.01.003","article-title":"Hepatology may have problems with putative surrogate outcome measures","volume":"46","author":"Gluud","year":"2007","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0175|cit175","unstructured":"Gluud C Nikolova D Klingenberg SL Alexakis N Als-Nielsen B Colli A Cochrane Hepato-Biliary Group. About The Cochrane Collaboration (Cochrane Review Groups (CRGs)) 2011, Issue 10. Art. No.: LIVER"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0176|cit176","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S0140-6736(98)11293-X","article-title":"Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: a meta-analysis","volume":"354","author":"Goulis","year":"1999","journal-title":"Lancet"},{"issue":"4","key":"10.1002\/14651858.CD000551.pub3-BIB0177|cit177","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1053\/he.2000.5984","article-title":"Management of primary biliary cirrhosis. The American Association for the Study of Liver Diseases practice guidelines","volume":"31","author":"Heathcote","year":"2000","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0178|cit178","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0179|cit179","doi-asserted-by":"crossref","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 The Cochrane Collaboration, 2008. Available from www.cochrane-handbook.org","DOI":"10.1002\/9780470712184"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0180|cit180","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011] The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0181|cit181","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/00365529409103618","article-title":"Pharmacology of ursodeoxycholic acid, an enterohepatic drug","volume":"204","author":"Hofmann","year":"1994","journal-title":"Scandinavian Journal of Gastroenterology. Supplement"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0182|cit182","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1136\/bmj.319.7211.670","article-title":"What is meant by intention to treat analysis? Survey of published randomised controlled trials","volume":"319","author":"Hollis","year":"1999","journal-title":"British Medical Journal (Clinical Research Ed.)"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0183|cit183","volume-title":"Code of Federal Regulation & ICH Guidelines","author":"International Conference on Harmonisation of Technical Requiements for Registration of Pharmaceuticals for Human Use","year":"1997"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0184|cit184","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0016-5085(94)94899-2","article-title":"Kinetics of hepatic bile acid handling in cholestatic liver disease: effect of ursodeoxycholic acid","volume":"106","author":"Jazrawi","year":"1994","journal-title":"Gastroenterogy"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0185|cit185","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1056\/NEJMra043898","article-title":"Primary biliary cirrhosis","volume":"353","author":"Kaplan","year":"2005","journal-title":"New England Journal of Medicine"},{"issue":"11","key":"10.1002\/14651858.CD000551.pub3-BIB0186|cit186","doi-asserted-by":"crossref","first-page":"982","DOI":"10.7326\/0003-4819-135-11-200112040-00010","article-title":"Reported methodological quality and discrepancies between large and small randomised trials in meta-analyses","volume":"135","author":"Kjaergard","year":"2001","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0187|cit187","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1055\/s-2000-9426","article-title":"Hepatic transport of bile salts","volume":"20","author":"Kullak-Ublick","year":"2000","journal-title":"Seminars in Liver Disease"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0188|cit188","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.jhep.2005.06.017","article-title":"Agreement between reported use of interventions for liver diseases and research evidence in Cochrane systematic reviews","volume":"43","author":"K\u00fcrstein","year":"2005","journal-title":"Journal of Hepatology"},{"issue":"1","key":"10.1002\/14651858.CD000551.pub3-BIB0189|cit189","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0168-8278(01)00092-7","article-title":"Ursodeoxycholic acid 'mechanisms of action and clinical use in hepatobiliary disorders","volume":"35","author":"Lazaridis","year":"2001","journal-title":"Journal of Hepatology"},{"issue":"3","key":"10.1002\/14651858.CD000551.pub3-BIB0190|cit190","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1055\/s-2005-916323","article-title":"The natural history of PBC: has it changed?","volume":"25","author":"Lee","year":"2005","journal-title":"Seminars in Liver Disease"},{"issue":"2","key":"10.1002\/14651858.CD000551.pub3-BIB0191|cit191","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF00432479","article-title":"Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis)","volume":"379","author":"Ludwig","year":"1978","journal-title":"Virchows Archiv. A. Pathological Anatomy and Histology"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0192|cit192","doi-asserted-by":"crossref","first-page":"121","DOI":"10.7326\/0003-4819-30-1-121","article-title":"Xanthomatous biliary cirrhosis (a clinical syndrome)","volume":"30","author":"MacMahon","year":"1949","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0193|cit193","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/ncpgasthep0360","article-title":"Patients and patience: the pitfalls of primary biliary cirrhosis trials","volume":"2","author":"Mayo","year":"2005","journal-title":"Nature Clinical Practise Gastroenterology & Hepatology"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0194|cit194","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0140-6736(98)01085-X","article-title":"Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?","volume":"352","author":"Moher","year":"1998","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0195|cit195","first-page":"415","article-title":"No symptomatic or histological benefit from ursodeoxycholic acid treatment in PBC after 1 year. Controlled pilot study [IASL abstract]","volume":"12","author":"Myszor","year":"1990","journal-title":"Hepatology"},{"issue":"3","key":"10.1002\/14651858.CD000551.pub3-BIB0196|cit196","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1053\/j.gastro.2005.12.029","article-title":"Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic acid","volume":"130","author":"Pares","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0197|cit197","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/hep.510290116","article-title":"Cost-effectiveness of ursodeoxycholic acid therapy in primary biliary cirrhosis","volume":"29","author":"Pasha","year":"1999","journal-title":"Hepatology"},{"issue":"3","key":"10.1002\/14651858.CD000551.pub3-BIB0198|cit198","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1053\/jhep.2002.36088","article-title":"Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited","volume":"36","author":"Paumgartner","year":"2002","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0199|cit199","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/S0016-5085(97)70183-5","article-title":"Combined analysis of randomised controlled trials of ursodeoxycholic acid in primary biliary cirrhosis","volume":"113","author":"Poupon","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0200|cit200","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0168-8278(00)80232-9","article-title":"Ursodeoxycholic acid for primary biliary cirrhosis: lessons from the past - issues for the future","volume":"32","author":"Poupon","year":"2000","journal-title":"Journal of Hepatology"},{"issue":"5","key":"10.1002\/14651858.CD000551.pub3-BIB0201|cit201","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.jhep.2009.11.027","article-title":"Primary biliary cirrhosis: a 2010 update","volume":"52","author":"Poupon","year":"2010","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0202|cit202","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1053\/gast.2002.36027","article-title":"Survival and symptom progression in a geographically based cohort of patients with primary biliary cirrhosis: follow-up for up to 28 years","volume":"123","author":"Prince","year":"2002","journal-title":"Gatroenterology"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0203|cit203","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S1089-3261(03)00102-8","article-title":"The epidemiology of primary biliary cirrhosis","volume":"7","author":"Prince","year":"2003","journal-title":"Clinics in Liver Disease"},{"issue":"6","key":"10.1002\/14651858.CD000551.pub3-BIB0204|cit204","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1136\/gut.2003.023937","article-title":"Asymptomatic primary biliary cirrhosis: clinical features, prognosis, and symptom progression in a large population based cohort","volume":"53","author":"Prince","year":"2004","journal-title":"Gut"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0205|cit205","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2011"},{"issue":"4","key":"10.1002\/14651858.CD000551.pub3-BIB0206|cit206","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1017\/S0266462303000552","article-title":"Literature searching for randomised controlled trials used in Cochrane reviews: rapid versus exhaustive searches","volume":"19","author":"Royle","year":"2003","journal-title":"International Journal of Technology Assessment in Health Care"},{"issue":"2","key":"10.1002\/14651858.CD000551.pub3-BIB0207|cit207","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1385\/CRIAI:28:2:135","article-title":"Medical treatment of primary biliary cirrhosis and primary sclerosing cholangitis","volume":"28","author":"Rust","year":"2005","journal-title":"Clinical Review in Allergy & Immunology"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0208|cit208","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1136\/pgmj.73.856.75","article-title":"Ursodeoxycholic acid in the treatment of liver diseases","volume":"73","author":"Saksena","year":"1997","journal-title":"Postgraduate Medical Journal"},{"issue":"6","key":"10.1002\/14651858.CD000551.pub3-BIB0209|cit209","doi-asserted-by":"crossref","first-page":"429","DOI":"10.7326\/0003-4819-157-6-201209180-00537","article-title":"Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials","volume":"157","author":"Savovi\u0107","year":"2012","journal-title":"Annals of Internal Medicine"},{"issue":"12","key":"10.1002\/14651858.CD000551.pub3-BIB0210|cit210","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1177\/003591576706001205","article-title":"Primary biliary cirrhosis","volume":"60","author":"Scheuer","year":"1967","journal-title":"Proceedings of the Royal Society of Medicine"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0211|cit211","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA"},{"issue":"3","key":"10.1002\/14651858.CD000551.pub3-BIB0212|cit212","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1136\/gut.38.3.439","article-title":"Metabolism of orally administered tauro-ursodeoxycholic acid in patients with primary biliary cirrhosis","volume":"38","author":"Setchell","year":"1996","journal-title":"Gut"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0213|cit213","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/gut.20.2.137","article-title":"Serum bilirubin: a prognostic factor in primary biliary","volume":"20","author":"Shapiro","year":"1979","journal-title":"Gut"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0214|cit214","first-page":"4216","article-title":"Metaanalysis regression","author":"Sharp","year":"1998","journal-title":"STATA Techn Bull"},{"issue":"2","key":"10.1002\/14651858.CD000551.pub3-BIB0215|cit215","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/00004836-200308000-00018","article-title":"Treatment with ursodeoxycholic acid is associated with weight gain in patients with primary biliary cirrhosis","volume":"37","author":"Siegel","year":"2003","journal-title":"Journal of Clinical Gastroenterology"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0216|cit216","first-page":"392","article-title":"Ursodeoxycholic therapy in chronic liver disease: a meta-analysis in primary biliary cirrhosis and in chronic hepatitis","volume":"89","author":"Simko","year":"1994","journal-title":"American Journal of Gastroenterology"},{"issue":"1","key":"10.1002\/14651858.CD000551.pub3-BIB0217|cit217","doi-asserted-by":"crossref","first-page":"195-209, viii","DOI":"10.1016\/S0889-8553(05)70050-9","article-title":"Mechanism of hepatoprotective action of bile salts in liver disease","volume":"28","author":"Stiehl","year":"1999","journal-title":"Gastroenterology Clinics of North America"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0218|cit218","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0140-6736(03)13808-1","article-title":"Primary biliary cirrhosis","volume":"362","author":"Talwalkar","year":"2003","journal-title":"Lancet"},{"issue":"11","key":"10.1002\/14651858.CD000551.pub3-BIB0219|cit219","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1002\/sim.1187","article-title":"How should meta-regression analyses be undertaken and interpreted?","volume":"21","author":"Thompson","year":"2002","journal-title":"Statistics in Medicine"},{"issue":"1","key":"10.1002\/14651858.CD000551.pub3-BIB0220|cit220","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/ije\/dyn179","article-title":"Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses","volume":"38","author":"Thorlund","year":"2009","journal-title":"International Journal of Epidemiology"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0221|cit221","unstructured":"Thorlund K Engstr\u00f8m J Wetterslev J Brok J Imberger G Gluud C User manual for trial sequential analysis (TSA) 2011"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0222|cit222","unstructured":"Thorlund K Engstr\u00f8m J Wetterslev J Brok J Imberger G Gluud C Trial Sequential Analysis 2011"},{"issue":"1","key":"10.1002\/14651858.CD000551.pub3-BIB0223|cit223","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jclinepi.2007.03.013","article-title":"Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis","volume":"61","author":"Wetterslev","year":"2008","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD000551.pub3-BIB0224|cit224","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1471-2288-9-86","article-title":"Estimating required information size by quantifying diversity in random-effects model meta-analyses","volume":"9","author":"Wetterslev","year":"2009","journal-title":"BMC Medical Research Methodology"},{"issue":"7644","key":"10.1002\/14651858.CD000551.pub3-BIB0225|cit225","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1136\/bmj.39465.451748.AD","article-title":"Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study","volume":"336","author":"Wood","year":"2008","journal-title":"British Medical Journal (Clinical Research Ed.)"},{"issue":"4","key":"10.1002\/14651858.CD000551.pub3-BIB0226|cit226","article-title":"Ursodeoxycholic acid for primary biliary cirrhosis","author":"Christensen","year":"1997","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD000551.pub3-BIB0227|cit227","article-title":"Ursodeoxycholic acid for primary biliary cirrhosis","author":"Gluud","year":"1999","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD000551.pub3-BIB0228|cit228","first-page":"83","article-title":"Ursodeoxycholic acid (UDCA) in primary biliary cirrhosis (PBC) - a Cochrane Hepato-Biliary systematic review","volume":"30","author":"Gluud","year":"1999","journal-title":"Journal of Hepatology"},{"issue":"4","key":"10.1002\/14651858.CD000551.pub3-BIB0229|cit229","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000551","article-title":"Ursodeoxycholic acid for primary biliary cirrhosis","author":"Gluud","year":"2001","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD000551.pub3-BIB0230|cit230","first-page":"CD000551","article-title":"Ursodeoxycholic acid for primary biliary cirrhosis","volume":"16","author":"Gong","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD000551.pub3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T03:47:53Z","timestamp":1747021673000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD000551.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Hepato-Biliary Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,12,12]]},"references-count":230,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2012,12]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd000551.pub3","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717969424.793469137","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.717969424.793469265","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.717969424.793469694","asserted-by":"object"}]},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,12]]}}}